U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07253987) titled 'Cancer Survivors Program' on Nov. 19.
Brief Summary: The questionnaire for assessment of adverse events after completion of cancer treatment, which is being piloted at the Masaryk Memorial Cancer Institute, aims to detect a wide range of adverse effects early on, thus facilitating adequate intervention and planning of follow-up care for all cancer survivors.
Study Start Date: May 05
Study Type: INTERVENTIONAL
Condition:
Prostate Cancer Patients
Breast Cancer Patients
Intervention:
OTHER: active screening of adverse effects of anticancer therapy based on specific questionnaire + quality of life screening
Based on the Questionn...